Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Koeberle

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|November 21, 2007
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98Dieter Koeberle, Beat Thuerlimann
Oncology Research and Treatment|January 13, 2021
Targeting HER2 in Biliary Tract Carcinomas: Challenges and OpportunitiesDieter Koeberle, Ralph Fritsch
Expert Review of Anticancer Therapy|December 27, 2005
Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancerDieter Koeberle, Beat Thuerlimann
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2008
Excruciating thigh pain and hepatic air collectionDieter Koeberle, Irene Peter, Katia Boggian
Journal of the National Cancer Institute|April 8, 2004
Re: Playing the old piano: another tune for endocrine therapyDieter Koeberle, Lucien Perey, Beat Thuerlimann, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendationsBeat Thuerlimann, Dieter Koeberle, Hans-Joerg Senn
Hematological Oncology|July 7, 2011
Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinibMichael Baumann, Thomas Cerny, Andreas Sommacal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Is there really enough evidence to abandon surgery after radiation chemotherapy in esophageal cancer?Thomas Ruhstaller, Andreas Mueller, Dieter Koeberle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Between utter despair and essential hopeMonika Renz, Dieter Koeberle, Thomas Cerny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?Thomas Ruhstaller, Beat Thuerlimann, Dieter Koeberle, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|November 21, 2007
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98Dieter Koeberle, Beat Thuerlimann
Oncology Research and Treatment|January 13, 2021
Targeting HER2 in Biliary Tract Carcinomas: Challenges and OpportunitiesDieter Koeberle, Ralph Fritsch
Expert Review of Anticancer Therapy|December 27, 2005
Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancerDieter Koeberle, Beat Thuerlimann
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2008
Excruciating thigh pain and hepatic air collectionDieter Koeberle, Irene Peter, Katia Boggian
Journal of the National Cancer Institute|April 8, 2004
Re: Playing the old piano: another tune for endocrine therapyDieter Koeberle, Lucien Perey, Beat Thuerlimann, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendationsBeat Thuerlimann, Dieter Koeberle, Hans-Joerg Senn
Hematological Oncology|July 7, 2011
Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinibMichael Baumann, Thomas Cerny, Andreas Sommacal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Is there really enough evidence to abandon surgery after radiation chemotherapy in esophageal cancer?Thomas Ruhstaller, Andreas Mueller, Dieter Koeberle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Between utter despair and essential hopeMonika Renz, Dieter Koeberle, Thomas Cerny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?Thomas Ruhstaller, Beat Thuerlimann, Dieter Koeberle, et al.
Pageof 5